aai congressional briefing

aai congressional briefing

Chronic Disease Management vs Congressional Obstacles?

Chronic Disease Management vs Congressional Obstacles? In 2023, a single 30-minute AAI congressional briefing increased reimbursement approval rates for a breakthrough autoimmune therapy by 45 percent. This shows that targeted policy engagement can overturn legislative obstacles that hinder chronic disease management. Medical Disclaimer: This article is for informational purposes only